These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 19380698

  • 1. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome.
    Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA.
    Neurology; 2009 Apr 21; 72(16):1390-6. PubMed ID: 19380698
    [Abstract] [Full Text] [Related]

  • 2. Increased ventral striatal monoaminergic innervation in Tourette syndrome.
    Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA.
    Neurology; 2003 Aug 12; 61(3):310-5. PubMed ID: 12913189
    [Abstract] [Full Text] [Related]

  • 3. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.
    Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL.
    Neurology; 1999 Jul 22; 53(2):371-4. PubMed ID: 10430428
    [Abstract] [Full Text] [Related]

  • 4. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ.
    Ann Neurol; 2000 Apr 22; 47(4):493-503. PubMed ID: 10762161
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN.
    Eur Neuropsychopharmacol; 2013 Nov 22; 23(11):1423-31. PubMed ID: 23876376
    [Abstract] [Full Text] [Related]

  • 6. Extrastriatal dopaminergic dysfunction in tourette syndrome.
    Steeves TD, Ko JH, Kideckel DM, Rusjan P, Houle S, Sandor P, Lang AE, Strafella AP.
    Ann Neurol; 2010 Feb 22; 67(2):170-81. PubMed ID: 20225192
    [Abstract] [Full Text] [Related]

  • 7. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans.
    Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ.
    Synapse; 2010 Jun 22; 64(6):417-20. PubMed ID: 20169578
    [Abstract] [Full Text] [Related]

  • 8. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
    De La Fuente-Fernández R, Furtado S, Guttman M, Furukawa Y, Lee CS, Calne DB, Ruth TJ, Stoessl AJ.
    Synapse; 2003 Jul 22; 49(1):20-8. PubMed ID: 12710012
    [Abstract] [Full Text] [Related]

  • 9. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.
    Hum Brain Mapp; 2015 Jul 22; 36(7):2592-601. PubMed ID: 25788222
    [Abstract] [Full Text] [Related]

  • 10. Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome.
    Albin RL, Minderovic C, Koeppe RA.
    eNeuro; 2017 Jul 22; 4(4):. PubMed ID: 28791334
    [Abstract] [Full Text] [Related]

  • 11. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
    Kilbourn MR, Sherman PS, Kuszpit K.
    Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography.
    Sanchez-Catasus CA, Bohnen NI, Yeh FC, D'Cruz N, Kanel P, Müller MLTM.
    J Nucl Med; 2021 Apr 01; 62(4):545-552. PubMed ID: 32859707
    [Abstract] [Full Text] [Related]

  • 13. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.
    Hwang WJ, Yao WJ, Fu YK, Yang AS.
    Psychiatry Res; 2008 Feb 28; 162(2):159-66. PubMed ID: 18248965
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.
    Wong DF, Brasić JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, Nandi A, Maris MA, Alexander M, Ye W, Rousset O, Kumar A, Szabo Z, Gjedde A, Grace AA.
    Neuropsychopharmacology; 2008 May 28; 33(6):1239-51. PubMed ID: 17987065
    [Abstract] [Full Text] [Related]

  • 15. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
    Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ.
    J Neurosci; 2008 Sep 24; 28(39):9850-6. PubMed ID: 18815269
    [Abstract] [Full Text] [Related]

  • 16. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
    Tong J, Wilson AA, Boileau I, Houle S, Kish SJ.
    Synapse; 2008 Nov 24; 62(11):873-6. PubMed ID: 18720517
    [Abstract] [Full Text] [Related]

  • 17. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA.
    Neuropsychopharmacology; 2000 Dec 24; 23(6):667-75. PubMed ID: 11063922
    [Abstract] [Full Text] [Related]

  • 18. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA, Stokholm K, Zareba-Paslawska J, Jakobsen S, Vang K, Gjedde A, Landau AM, Romero-Ramos M.
    Sci Rep; 2017 Jul 25; 7(1):6363. PubMed ID: 28743955
    [Abstract] [Full Text] [Related]

  • 19. Decreased striatal monoaminergic terminals in Huntington disease.
    Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL.
    Neurology; 2000 May 09; 54(9):1753-9. PubMed ID: 10802780
    [Abstract] [Full Text] [Related]

  • 20. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
    Martin WR, Wieler M, Stoessl AJ, Schulzer M.
    Ann Neurol; 2008 Mar 09; 63(3):388-94. PubMed ID: 18240153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.